SEC Form 4 research
| Issuer | Compass Therapeutics, Inc. |
|---|---|
| Tickers | CMPX |
| Reporting owners | 26 |
| Officers and directors | 7 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-10-01 | Lerner Neil | P | 20,000 | $0.92 | Not reported |
| 2026-09-25 | 2026-09-24 | Lerner Neil | P | 2,500 | $1.14 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.